Cingulate Inc. Shares Outstanding
Cingulate Inc. (CING) had Shares Outstanding of 13.89 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-13
- 2026-06-30: Shares outstanding (split-adjusted) 13.89M shares; Shares authorized (split-adjusted) 240.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 11.91M shares; Shares authorized (split-adjusted) 240.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 7.25M shares; Shares authorized (split-adjusted) 240.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 5.98M shares; Shares authorized (split-adjusted) 240.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 13.89M shares 10-Q · filed 2026-08-13 | 240.00M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 11.91M shares 10-Q · filed 2026-05-14 | 240.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 7.25M shares 10-Q · filed 2026-08-13 | 240.00M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 5.98M shares 10-Q · filed 2025-11-13 | 240.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 4.89M shares 10-Q · filed 2025-08-19 | 240.00M shares 10-Q · filed 2025-08-19 |
| 2025-03-31 | 3.83M shares 10-Q · filed 2025-05-08 | 240.00M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 3.40M shares 10-K · filed 2026-03-18 | 240.00M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 3.04M shares 10-Q · filed 2024-11-07 | 240.00M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 780.76K shares 10-Q · filed 2024-08-13 | (m) |
| 2024-03-31 | 5.01M shares 10-Q · filed 2024-05-08 | 240.00M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 97.29K shares 10-K · filed 2025-03-27 | 240.00M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 17.38M shares 10-Q · filed 2023-11-13 | 240.00M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 12.06M shares 10-Q · filed 2023-08-14 | 240.00M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 11.31M shares 10-Q · filed 2023-05-10 | 240.00M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 602.64K shares 10-K · filed 2024-04-01 | 240.00M shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 11.31M shares 10-Q · filed 2022-11-14 | 240.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 11.31M shares 10-Q · filed 2022-08-11 | 240.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 11.31M shares 10-Q · filed 2022-05-12 | 240.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 11.31M shares 10-K · filed 2023-03-10 | 240.00M shares 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |